News & Press

BAS Research featured on Dr Oz
BAS Research featured on Dr Oz

On an episode of “The Dr. Oz Show,” Montel Williams takes viewers inside BAS Research.

Cannabis Business Takes Hold in State
Cannabis Business Takes Hold in State

Manufacturers were quick to capitalize on Berkeley’s cannabis-friendly regulations. BAS Research, a company developing “science-driven” methods for cannabis extraction and manufacturing, was also granted a license that year.

BAS Research’s CEO, Dr. Bao Le Interviewed by The Sacramento Bee
BAS Research’s CEO, Dr. Bao Le Interviewed by The Sacramento Bee

Dr. Bao Le got into the medical marijuana business about eight years ago after his son was diagnosed with autism...

BAS Research’s CSO, Robert Sindelar Interviewed by Herb
BAS Research’s CSO, Robert Sindelar Interviewed by Herb

We spoke with some industry experts from BAS Research and Cloudponics to see there’s any truth to this age-old stoner binary: Indica or Sativa?

OUR REASON

These are the stories that inspire us to focus on our mission – to heal the world by
making safe cannabis and hemp-based products.

Meet the First Baby Ever Treated with Cannabis CBD Oil at The Hospital
Meet the First Baby Ever Treated with Cannabis CBD Oil at The Hospital

For the first time ever, cannabis oil will be used in a hospital... To save a 2-month-old baby girl

Cannabidiol significantly reduces seizures in patients with severe form of epilepsy
Cannabidiol significantly reduces seizures in patients with severe form of epilepsy

A new large-scale, randomized, controlled trial was able to significantly reduce the number of dangerous seizures in patients with a severe form of epilepsy called Lennox-Gastaut syndrome.

Cannabidiol helps reduce seizures in people with severe form of epilepsy, study suggests
Cannabidiol helps reduce seizures in people with severe form of epilepsy, study suggests

A key cannabis compound helped to reduce the number of drop seizures in patients with a severe form of epilepsy, newly published results of a clinical trial suggest.

A drug derived from cannabis may be the first of its kind to treat a rare form of epilepsy
A drug derived from cannabis may be the first of its kind to treat a rare form of epilepsy

An experimental drug derived from cannabis to treat epilepsy is on the brink of becoming the first of its kind to win US government approval.

OUR COLLABORATION

Meet some of the partners that we collaborate with every day.

BAS Research @ MJBizCon – 2017 Recap
BAS Research @ MJBizCon – 2017 Recap

A recap of everything that happened at the BAS Booth on the 2017 edition of MJBizCon.

BAS Research @ MJBizCon – Eel River Organics Interview
BAS Research @ MJBizCon – Eel River Organics Interview

Dr. Bao Le interviews Brieanne Mirjah - Director of Sales and Marketing - Eel River Organics

BAS Research @ MJBizCon – Seven Points Interview
BAS Research @ MJBizCon – Seven Points Interview

Dr. Bao Le interviews Glenn Kassel - Seven Points Group

PRESS RELEASES

New partnerships and clients announcements.

BAS Research Announces Receipt of Cannabis Distribution License
BAS Research Announces Receipt of Cannabis Distribution License

Company to bring distribution in-house to further service brands like Dr. Kerklaan Therapeutics

BAS Research Names Cecily Brewster, Cannabis Commissioner for the City of Berkeley, to General Counsel
BAS Research Names Cecily Brewster, Cannabis Commissioner for the City of Berkeley, to General Counsel

Former San Francisco Assistant DA and UC Berkeley alumna joins BAS Research to lead legal, government relations and corporate secretary functions

BAS Research Executes Agreement for Exclusive Manufacturing Rights to Dr. Raw Organics
BAS Research Executes Agreement for Exclusive Manufacturing Rights to Dr. Raw Organics

Partnership will encompass full line of premium, 100% organic cannabis edibles, concentrates and topical products in California

Resources & Press Inquiry

Logos & Lab Photos

We would love to answer any question you may have!

Contact us at: press@basresearch.com

Leave a Reply